Published in Sex Transm Infect on December 01, 2006
Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect (2006) 1.80
Where do young men want to access STI screening? A stratified random probability sample survey of young men in Great Britain. Sex Transm Infect (2012) 1.72
Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data. Sex Transm Infect (2011) 1.62
The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect (2007) 1.39
Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health (2009) 1.21
What needs to change to increase chlamydia screening in general practice in Australia? The views of general practitioners. BMC Public Health (2008) 1.12
Young men's views toward the barriers and facilitators of Internet-based Chlamydia trachomatis screening: qualitative study. J Med Internet Res (2013) 1.05
Using educational outreach and a financial incentive to increase general practices' contribution to chlamydia screening in South-East London 2003-2011. BMC Public Health (2012) 1.02
Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening. BMC Public Health (2012) 0.87
Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation. Epidemiol Infect (2013) 0.85
C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010. PLoS One (2013) 0.84
Management of epididymo-orchitis in primary care: results from a large UK primary care database. Br J Gen Pract (2010) 0.83
Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect (2015) 0.83
Determinants of sexual network structure and their impact on cumulative network measures. PLoS Comput Biol (2012) 0.81
Do sexual health campaigns work? An outcome evaluation of a media campaign to increase chlamydia testing among young people aged 15-24 in England. BMC Public Health (2013) 0.80
Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates. PLoS One (2013) 0.80
Population movement can sustain STI prevalence in remote Australian indigenous communities. BMC Infect Dis (2013) 0.79
Disease dynamics and costly punishment can foster socially imposed monogamy. Nat Commun (2016) 0.78
Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis. BMC Public Health (2015) 0.77
Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012). PLoS One (2017) 0.75
Chlamydia screening in England: a qualitative study of the narrative behind the policy. BMC Public Health (2012) 0.75
Incidence and predictors of annual chlamydia testing among 15-29 year olds attending Aboriginal primary health care services in New South Wales, Australia. BMC Health Serv Res (2015) 0.75
Exploring why a complex intervention piloted in general practices did not result in an increase in chlamydia screening and diagnosis: a qualitative evaluation using the fidelity of implementation model. BMC Fam Pract (2017) 0.75
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet (2001) 13.31
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol (1991) 6.49
The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis (2005) 3.53
Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settings. Sex Transm Infect (2003) 3.00
Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med (2004) 2.95
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect (2004) 2.92
Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78
The role of sexual partnership networks in the epidemiology of gonorrhea. Sex Transm Dis (1997) 2.69
Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect (2005) 2.53
Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis (1997) 2.42
Chlamydia trachomatis infections: progress and problems. J Infect Dis (1999) 2.19
Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update (1999) 2.12
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect (2004) 2.05
Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. Br J Gen Pract (2006) 1.75
Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol (2001) 1.60
The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis (1999) 1.58
Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med (1999) 1.47
Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis (2002) 1.29
Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model (2006) 1.22
Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. World Health Organization Task Force on the Prevention and Management of Infertility. Sex Transm Dis (1995) 1.21
Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis (2005) 1.14
Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections. Sex Transm Dis (2006) 1.05
The correct approach to modelling and evaluating chlamydia screening. Sex Transm Infect (2004) 0.97
Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention. Sex Transm Dis (2004) 0.96
The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis (2006) 0.89
Analysis of a successful immune response against hepatitis C virus. Immunity (1999) 6.31
Measles outbreaks in a population with declining vaccine uptake. Science (2003) 4.47
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect (2001) 2.98
Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ (2005) 2.72
Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect (2007) 2.72
Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol (1999) 2.42
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32
Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Infect (2002) 2.20
Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn (2008) 2.17
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine (2002) 2.12
Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect (2006) 2.09
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect (2004) 2.05
Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2007) 1.99
Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect (2000) 1.95
Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol (2003) 1.77
Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2004) 1.65
Close encounters of the infectious kind: methods to measure social mixing behaviour. Epidemiol Infect (2012) 1.64
Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol (2003) 1.61
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine (2009) 1.55
Impact of third- and fourth-degree perineal tears at first birth on subsequent pregnancy outcomes: a cohort study. BJOG (2014) 1.48
Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making (2003) 1.47
Health care providers' attention to food insecurity in households with children. Prev Med (2012) 1.47
Varicella vaccination: a double-edged sword? Commun Dis Public Health (2002) 1.43
The origins of HLA-A,B,C polymorphism. Immunol Rev (1995) 1.41
Re-training refugee and other overseas doctors: re-qualification through the United Examining Board examination. Clin Med (2006) 1.40
Recent trends in diagnoses of HIV and other sexually transmitted infections in England and Wales among men who have sex with men. Sex Transm Infect (2004) 1.37
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine (2004) 1.33
Third- and fourth-degree perineal tears among primiparous women in England between 2000 and 2012: time trends and risk factors. BJOG (2013) 1.32
The current burden of pneumococcal disease in England and Wales. J Infect (2006) 1.32
Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect (2008) 1.31
The natural history of meningococcal carriage and disease. Epidemiol Infect (2005) 1.29
Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine (2007) 1.25
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine (2007) 1.24
Modelling the healthcare costs of an opportunistic chlamydia screening programme. Sex Transm Infect (2004) 1.24
Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med (2001) 1.23
Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol (1995) 1.22
Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort. Epidemiol Infect (2011) 1.21
Varicella vaccination in England and Wales: cost-utility analysis. Arch Dis Child (2003) 1.20
Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect (2009) 1.20
Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol (2001) 1.17
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis (2006) 1.17
The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant (2001) 1.17
The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess (2010) 1.15
Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol (1999) 1.14
The contribution of respiratory pathogens to the seasonality of NHS Direct calls. J Infect (2007) 1.13
Implementation of IMRT in the radiotherapy department. Br J Radiol (2003) 1.07
The cost-effectiveness of varicella vaccination in Canada. Vaccine (2002) 1.07
Factors associated with HIV seroconversion in gay men in England at the start of the 21st century. Sex Transm Infect (2007) 1.06
The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis. J Viral Hepat (2008) 1.05
The seroepidemiology of measles in Western Europe. Epidemiol Infect (2001) 1.04
Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Med Decis Making (2006) 1.03
Paraspinal abscess complicating facet joint injection. Clin Nucl Med (2000) 1.02
Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. Health Econ (2008) 0.99
Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy. Clin Oncol (R Coll Radiol) (2010) 0.98
Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med (2001) 0.98
Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics. Neurotox Res (2006) 0.98
The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens (1994) 0.96
Continuing improvement in cadaver donor graft survival in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant (2000) 0.95
Characteristics of children having multiple Medicaid-paid asthma hospitalizations. Matern Child Health J (1998) 0.95
A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol (2004) 0.95
Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now? Sex Transm Infect (2006) 0.93
The seroepidemiology of rubella in western Europe. Epidemiol Infect (2000) 0.93
CK-1, a putative chemokine of rainbow trout (Oncorhynchus mykiss). Immunol Rev (1998) 0.92
Immunity to diphtheria and tetanus in England and Wales. Vaccine (2000) 0.92
The changing epidemiology of infectious mononucleosis? J Infect (2002) 0.91
The cost of measles in industrialised countries. Vaccine (2003) 0.91
Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal. Med Decis Making (2011) 0.90
Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance. Sex Transm Infect (2007) 0.88
Recent outbreaks of infectious syphilis, United Kingdom, January 2012 to April 2014. Euro Surveill (2014) 0.88
A major histocompatibility complex class I allele shared by two species of chimpanzee. Immunogenetics (1998) 0.87
A Comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radiat Oncol Biol Phys (2000) 0.87
Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E. Tissue Antigens (1996) 0.87
A decade of living donor transplantation in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant (2000) 0.87
Modelling the hepatitis B vaccination programme in prisons. Epidemiol Infect (2006) 0.86
Sero-epidemiology of mumps in western Europe. Epidemiol Infect (2003) 0.86
Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine (2000) 0.86
Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiol Infect (2006) 0.85
A community study of health promotion in rural West Africa: details of a household survey and population census. QJM (2002) 0.85
Rapid diagnosis of sedative intoxication by gas chromatography. Ann Intern Med (1970) 0.84
An investigation into methods of IMRT planning applied to breast radiotherapy. Br J Radiol (2008) 0.84
Social ties and susceptibility to the common cold. JAMA (1997) 0.83
SPET of a computerised model of diffuse lung disease. Eur J Nucl Med (2001) 0.83
Developed countries could pay for hepatitis B vaccination in developing countries. BMJ (1998) 0.82
Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine (2005) 0.82
Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas. Tissue Antigens (1997) 0.82
Chrysiasis: the role of sun exposure in dermal hyperpigmentation secondary to gold therapy. J Rheumatol (1986) 0.81
Immunity and exposure to hepatitis A virus in pre-adolescent children from a multi-ethnic inner city area. Commun Dis Public Health (2004) 0.80
Health professionals do not understand mathematical models. BMJ (2000) 0.79
Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys (1999) 0.79
The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. Tissue Antigens (1995) 0.78
The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles. Vaccine (2005) 0.78
A urinary control device for management of female stress incontinence. Obstet Gynecol (2000) 0.78
A small test of a sequence-based typing method: definition of the B*1520 allele. Tissue Antigens (1994) 0.78
Platelet activation in acute pulmonary embolism. J Thromb Haemost (2007) 0.78
Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol (1997) 0.77
A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles. J Med Chem (1990) 0.77